Skip Navigation

Pharmacology

Citations 81-90 of 165 total displayed.

Past content (since Dec 2002):

LETTERS TO THE EDITOR
Screening for Mycobacterium tuberculosis prior to anti-TNF therapy––an audit of impact of the British Thoracic Society guidelines on rheumatology practice in an area of low Mycobacterium tuberculosis prevalence
J. D. Pradeep, G. P. R. Clunie, K. Gaffney, N. J. Innes, A. Brooksby, P. Bradley, and A. Gulati
Rheumatology 2009; 48: 195-a. [Extract] [Full Text]  

LETTERS TO THE EDITOR
Assessment of the impact of new UK guidelines on the management of aromatase inhibitor-associated bone loss
E. Sowden, B. Evans, C. M. Greenbank, M. Bukhari, and J. P. Halsey
Rheumatology 2009; 48: 197-198. [Extract] [Full Text]  

CASE REPORTS
Severe acute thrombotic exacerbation in two cases with anti-phospholipid syndrome after retreatment with rituximab in phase I/II clinical trial for refractory systemic lupus erythematosus
K. Suzuki, H. Nagasawa, H. Kameda, K. Amano, T. Kondo, S. Itoyama, Y. Tanaka, and T. Takeuchi
Rheumatology 2009; 48: 198-199. [Extract] [Full Text]  

EDITORIALS
Imatinib as a novel therapeutic approach for fibrotic disorders
J. H. W. Distler and O. Distler
Rheumatology 2009; 48: 2-4. [Extract] [Full Text]  

CLINICAL
A novel therapeutic approach to the treatment of scleroderma-associated pulmonary complications: safety and efficacy of combination therapy with imatinib and cyclophosphamide
I. Sabnani, M. J. Zucker, E. D. Rosenstein, D. A. Baran, L. H. Arroyo, P. Tsang, M. Zubair, and V. Rivera
Rheumatology 2009; 48: 49-52. [Abstract] [Full Text]  

CLINICAL
Contemporary patterns of care and disease activity outcome in early rheumatoid arthritis: the ERAN cohort
P. Kiely, R. Williams, D. Walsh, and A. Young for the Early Rheumatoid Arthritis Network (ERAN)
Rheumatology 2009; 48: 57-60. [Abstract] [Full Text] [ Supplementary Data ]  

EDITORIALS
What is the most important outcome parameter in ankylosing spondylitis?
J. Braun and J. Sieper
Rheumatology 2008; 47: 1738-1740. [Extract] [Full Text]  

REVIEWS
Amitriptyline in the treatment of fibromyalgia: a systematic review of its efficacy
B. Nishishinya, G. Urrútia, B. Walitt, A. Rodriguez, X. Bonfill, C. Alegre, and G. Darko
Rheumatology 2008; 47: 1741-1746. [Abstract] [Full Text]  

CASE REPORTS
Long-term tocilizumab therapy in a patient with rheumatoid arthritis and chronic hepatitis B
T. Nagashima and S. Minota
Rheumatology 2008; 47: 1838-a--a1840. [Extract] [Full Text]  

EDITORIALS
Why do the French get much greater access to anti-TNF than the British? Vive la différence? Pas nécessairement
C. Deighton and K. Hyrich
Rheumatology 2008; 47: 1600-1602. [Extract] [Full Text]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

* Collected Resources Home

* Related collections:
 Rheumatology
 Benign Joint Hypermobility Syndrome
 Crystal Arthritis
 Diagnostics and Imaging Procedures
 Education
 Experimental Arthritis
 Fibromyalgia
 Health Economics
 Historical Medicine
 Immunogenetics
 Myositis and Muscle Disease
 Osteoarthritis and Cartilage
 Osteoporosis and Metabolic Bone Disease
 Pharmacology
 Pregnancy and Rheumatic Diseases
 Psychology: Measurement and Management of Pain
 Rehabilitation
 Rheumatoid Arthritis
 Sjogren's Syndrome
 Soft Tissue Rheumatism
 Spinal Pain
 Spondylarthropathies
 Systemic Lupus Erythematosus and Autoimmunity
 Systemic Sclerosis
 Vasculitis